Peoples Bank KS lessened its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 0.6% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 10,336 shares of the company’s stock after selling 65 shares during the quarter. Procter & Gamble comprises approximately 1.2% of Peoples Bank KS’s holdings, making the stock its 21st biggest position. Peoples Bank KS’s holdings in Procter & Gamble were worth $1,733,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of the business. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble in the second quarter worth $28,000. Fairway Wealth LLC bought a new stake in Procter & Gamble in the 2nd quarter valued at about $29,000. RPg Family Wealth Advisory LLC purchased a new stake in Procter & Gamble during the third quarter valued at about $33,000. Quest Partners LLC bought a new position in Procter & Gamble during the second quarter worth about $36,000. Finally, Fairfield Financial Advisors LTD purchased a new position in shares of Procter & Gamble in the second quarter worth about $44,000. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
NYSE:PG opened at $161.36 on Wednesday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The Procter & Gamble Company has a fifty-two week low of $146.28 and a fifty-two week high of $180.43. The business has a 50 day moving average price of $169.92 and a 200-day moving average price of $169.75. The firm has a market cap of $380.01 billion, a PE ratio of 27.82, a price-to-earnings-growth ratio of 3.70 and a beta of 0.45.
Analysts Set New Price Targets
Several research analysts recently commented on PG shares. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target for the company. in a research report on Monday, September 30th. DA Davidson restated a “buy” rating and issued a $209.00 target price on shares of Procter & Gamble in a research note on Friday, December 27th. JPMorgan Chase & Co. upped their price target on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Finally, Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Eight analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $179.75.
Read Our Latest Stock Report on PG
Insiders Place Their Bets
In other news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the completion of the sale, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. This trade represents a 54.48 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the transaction, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. The trade was a 12.63 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders sold 75,439 shares of company stock worth $13,317,460. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Investing In Preferred Stock vs. Common Stock
- U.S. Markets to Close for Jimmy Carter National Day of Mourning
- Business Services Stocks Investing
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- What Are Trending Stocks? Trending Stocks Explained
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.